These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11004913)
1. [Early treatment of IgA nephritis is indicated by prognostic factors]. Barth C Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1009. PubMed ID: 11004913 [No Abstract] [Full Text] [Related]
2. [Treatment of IGA nephritis]. Risler T; Braun N Dtsch Med Wochenschr; 2000 Aug; 125(34-35):996. PubMed ID: 11004910 [No Abstract] [Full Text] [Related]
3. [Treatment of IgA nephropathies: a critical viewpoint]. Mertens PR; Floege J Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1010. PubMed ID: 11004914 [No Abstract] [Full Text] [Related]
4. How did cyclophosphamide become the drug of choice for lupus nephritis? Bargman JM Nephrol Dial Transplant; 2009 Feb; 24(2):381-4. PubMed ID: 19056783 [No Abstract] [Full Text] [Related]
5. [Differentiated pathogenetic therapy of glomerulonephritis]. Belovezhdov N Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444 [No Abstract] [Full Text] [Related]
10. [Can we predict the risk of malignancy associated with dermatomyositis?]. Gainon J; Bart PA; Waeber G Praxis (Bern 1994); 2003 Oct; 92(41):1734-9. PubMed ID: 14587367 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring. Wang T; Weigt SS; Belperio JA; Lynch JP Semin Respir Crit Care Med; 2011 Jun; 32(3):346-70. PubMed ID: 21674420 [TBL] [Abstract][Full Text] [Related]
12. [Therapy in IgA nephropathy--when and how to do it]. Vas T; Kovács T; Késoi I; Sági B; Degrell P; Wittmann I; Nagy J Orv Hetil; 2011 Dec; 152(51):2039-46. PubMed ID: 22130201 [TBL] [Abstract][Full Text] [Related]
13. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases. Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyana M; Tateno S Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022 [No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil in IgA nephropathy. Sepe V; Rossi N; Adamo G; Dal Canton A Kidney Int; 2004 Oct; 66(4):1713; author reply 1713-4. PubMed ID: 15458475 [No Abstract] [Full Text] [Related]
15. Natural history of IgA nephropathy in Japan. Tojo S; Hatano M; Honda N; Miyahara T; Sugino N; Narita M; Sakai H Semin Nephrol; 1987 Dec; 7(4):386-8. PubMed ID: 3445023 [No Abstract] [Full Text] [Related]
16. [Clinical evidence of therapy of IgA nephropathy]. Gan WH; Zhang AQ; Ding GX; Gong J Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):101-3. PubMed ID: 17448301 [No Abstract] [Full Text] [Related]
17. A Modified Regimen of Methylprednisolone, Cyclophosphamide, and Mycophenolic Acid for Severe IgA Vasculitis with Nephritis in a Child. Pardede SO; Grace A; Saraswati M; Ambarsari CG Saudi J Kidney Dis Transpl; 2020; 31(5):1117-1124. PubMed ID: 33229778 [TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid. Bystryn JC Arch Dermatol; 2008 Jul; 144(7):946. PubMed ID: 18645153 [No Abstract] [Full Text] [Related]
19. [Treatment of pulmonary fibrosis]. Cottin V Presse Med; 2002 Oct; 31(34):1613-23. PubMed ID: 12426980 [TBL] [Abstract][Full Text] [Related]